ConductScience.org, home

Trial · NCT04235686

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Montgomery-Asberg Depression Rating Scale (MADRS) scoreBaseline to week 8 visit 10Reduction in Montgomery-Asberg Depression Rating Scale (MADRS) score (Range: 0-60) between Baseline and Week 8 visit 10
SecondaryChange in Quick Inventory for Depressive Symptomatology (QIDS-C and QIDS-SR) scoreBaseline to Week 8 visit 10Reduction in Clinician and self-report symptoms of depression as measured by the Quick Inventory for Depressive Symptomatology (QIDS-C and QIDS-SR) (Range: 0-27)
SecondaryRemissionBaseline to Week 8 visit 10Treatment remission (Montgomery-Asberg Depression Rating Scale (MADRS) score \< 10) (Range 0-60)
SecondaryChange in General Anxiety Disorder 7-item scale scoreBaseline to Week 8 visit 10Self-report anxiety as measured by the General Anxiety Disorder 7-item scale (GAD-7) (Range: 0-21)
SecondaryResponseBaseline to Week 8 visit 10Treatment response (50% reduction in Montgomery-Asberg Depression Rating Scale (MADRS) score (Range: 0-60)
SecondaryChange in Clinical Global Impression for Bipolar Disorder (CGI-BP) scoreBaseline to Week 8 visit 10Percentage of much or very much improved as measured by the Clinical Global Impression for Bipolar Disorder (CGI-BP) (Range: 1-8)
SecondaryChange in Young Mania Rating Scale (YMRS) scoreBaseline to Week 8 visit 10Reduction in sub-syndromal manic symptoms as measured by the Young Mania Rating Scale (YMRS) (Range: 0-56)
SecondaryChange in Epworth Sleepiness Scale (ESS) scoreBaseline to Week 8 visit 10Self-report likelihood of falling asleep during normal daily situations as measured by the Epworth Sleepiness Scale (ESS) (Range: 0-24)
SecondaryChange in Fatigue Severity Scale (FSS) scoreBaseline to Week 8 visit 10Self-report measure of fatigue as measured by the Fatigue Severity Scale (FSS) (Range: 0-63)
SecondaryChange in Binge Eating Scale (BES) scoreBaseline to Week 8 visit 10Self-report binge eating behavior as measured by the Binge Eating Scale (BES) (Range: 0-48)
SecondaryChange in Morningness-Eveningness Questionnaire (MEQ) scoreBaseline to Week 8 visit 10Self-Report measure on the Morningness-Eveningness Questionnaire (MEQ) (Range: 16-86)
SecondaryChange in Rapid Eating and Activity Assessment for Patients (REAP) scoreBaseline to Week 8 visit 10Self-Report measure on Rapid Eating and Activity Assessment for Patients (REAP) (Range: 0-27)
SecondaryChange in Digit Symbol Substitution Test (DSST) scoreBaseline to Week 8 visit 10Improvement in cognition as measured by the Digit Symbol Substitution Test (DSST) (Range: 0-100)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04235686/registered